The Maria Skłodowska-Curie National Research Institute of Oncology (MSCI) in Warsaw stands as a comprehensive cancer center. The Institute has branches in Gliwice, and Krakow and with Warsaw Campus accommodate approximately 25% of all cancer patients in Poland (over 130,000 hospitalized cancer patients, conducting 680,000 outpatient consultations, and diagnosing 50,000 new patients annually). The institute manages over 650 clinical trials (including 80 early-phase trials) focused on oncology.
The main MSCI campus has two buildings – research and clinical where each floor is a cancer-specific department (Department of Bone/Soft Tissue Sarcoma and Melanoma, Department of Central Nervous System Tumours, Department of Gynaecological Oncology, Department of Urological Cancer, Department of Lung Cancer & Thoracic Tumours, Department of Brest Cancer & Reconstructive Surgery, Department of Lymphoma, Department of Gastrointestinal Cancer, Department of Head & Neck Cancer, Department of Endocrine Cancer & Nuclear Medicine, Department of Cancer & Cardio-Oncology Diagnostics; Department of Oncology and Radiotherapy and Department of Oncological Surgery and Neuroendocrine Tumors).
In addition, there are Early Phase Clinical Trial Department, Day-One Hospital, Outpatient Clinics, the Hyperthermia Department, the Centre for Excellence in Precision Oncology, and CART Facility (under development). MSCI is a leader of the National Cancer Strategy, the National Oncology Network.
